medigraphic.com
ISSN 1727-897X (Electronic)

2022, Number 6

<< Back Next >>

Medisur 2022; 20 (6)

Serotypes and antimicrobial resistance of Streptococcus pneumoniae in Chinese pediatric population: a scoping review

Han X, Yu H, Molina ÁN, Toledo RME

Language: Spanish
References: 41
Page: 1187-1199
PDF size: 1053.85 Kb.


ABSTRACT

This review aimed to explore the serotype distribution and antimicrobial resistance of Streptococcus pneumoniae in the Chinese pediatric population based on literature published in the last six years. A scoping review was performed using PubMed and two Chinese databases: CNKI and WanFang Data. Of the total of 196 articles extracted, 14 studies were selected for this review. There are 13 articles that analyze the distribution of Streptococcus pneumoniae serotypes, the most frequently registered serotypes are: 19F, 19A, 23F, 14 and 6B. There are 11 articles that analyze the antimicrobial resistance of Streptococcus pneumoniae, the prevalence of non-susceptible to penicillin is in the range of 0% to 95.7%. Isolates are highly resistant to erythromycin, clindamycin, tetracycline, and trimethoprim-sulfamethoxazole; they are resistant to penicillin in pneumococcal meningitis but are sensitive to penicillin in other pneumococcal diseases, in addition, they are very sensitive to levofloxacin, vancomycin and Linezolid. It is concluded that the pneumococcal conjugate vaccine 13 has high coverage in Streptococcus pneumoniae serotypes in children from mainland China, therefore its inclusion in the childhood vaccination program is recommended; at the same time, the occurrence of serotype substitution should be taken into account. Therefore, more pediatric patients or children should be included in research, especially those under five years of age. Long-term, high-quality surveillance of the serotype distribution and antimicrobial resistance of Streptococcus pneumoniae is necessary for the development of pneumococcal disease prevention.


REFERENCES

  1. Organización Mundial de la Salud. Neumonía[Internet]. Ginebra: OMS; 2019[citado 20/02/2022]. Disponible en: Disponible en: https://www.who.int/es/news-room/fact-sheets/detail/pneumonia; 2019 1.

  2. Organización Mundial de la Salud. Pneumococcal vaccines WHO position paper-2012-Recommendations. Vaccine. 2012; 30(32):4717-8.

  3. Equipo editorial. Chinese Maternal and Child Health Development Report. Chinese J Women and Children Health. 2019;10(05):1-8.

  4. Zhou X, Liu J, Zhang Z, Liu Y, Wang Y, Liu Y. Molecular characteristics of penicillin-binding protein 2b, 2x and 1a sequences in Streptococcus pneumoniae isolates causing invasive diseases among children in Northeast China. Eur J Clin Microbiol Infect Dis. 2016;35(4):633-45.

  5. Lyu S, Hu Hl, Yang Yh, Kai Y. A systematic review about Streptococcus Pneumoniae serotype distribution in children in mainland of China before the PCV13 was licensed. Expert Rev Vaccines. 2017;16(10):997-1006.

  6. Noda Albelo A, Vidal Tallet LA, Vidal Tallet JI, Hernández Álvarez L. Streptococcus pneumoniae, mecanismos de resistencia antimicrobiana. Rev Cubana Pediatr. 2011;83(3):288-95. .

  7. Jefferies JM, Macdonald E, Faust SN, Clarke S. 13-valent pneumococcal conjugate vaccine (PCV13). Human Vaccines. 2011;7(10):1012-8.

  8. Armstrong R, Hall BJ, Doyle J, Water E. 'Scoping the scope'of a cochrane review. Journal of Public Health. 2011;33(1):147-50.

  9. Tricco AC, Lillie E, Zarin W, O´Brien K, Colquhoun H, Levac D, et al. PRISMA extension for scoping reviews (PRISMA-ScR): checklist and explanation. Ann Intern Med. 2018 Oct 2;169(7):467-473.

  10. Wang Q, Shi W, Li Y. Serotype distribution of Streptococcus pneumoniae isolated from children hospitalized in Beijing children's hospital (2013-2019). Vaccine. 2020;38(49):7858-64.

  11. Shi W, Li J, Dong F, Qian S, Liu G, Xu B, et al. Serotype distribution, antibiotic resistance pattern, and multilocus sequence types of invasive Streptococcus pneumoniae isolates in two tertiary pediatric hospitals in Beijing prior to PCV13 availability. Expert Rev Vaccines. 2019;18(1):89-94.

  12. Zhao W, Pan F, Wang BJ, Wang C, Sun Y, Zhang T, et al. Epidemiology characteristics of Streptococcus pneumoniae from children with pneumonia in Shanghai: a retrospective study. Front Cell Infect Microbiol. 2019;9:258.

  13. Wang X, Cong Z, Huang W, Li C. Molecular characterization of Streptococcus pneumoniae isolated from pediatric patients in Shanghai, China. Pediatr Pulmonol. 2020;55(8):2135-41.

  14. Tang J, Huang XX, Zhang K, Rongsong Y. Molecular characterization of Streptococcus pneumoniae isolated from pediatric patients in Shanghai, China. Vaccine. 2020;19(1):48-53.

  15. Kang LH, Liu MJ, Xu WC. Molecular epidemiology of pneumococcal isolates from children in China. Saudi Medical J. 2016;37(4):403.

  16. Chen KL, Zhang XY, Tao YZ, Wang Y, Xue J, Liu Ch, et al. Hospitalization for invasive pneumococcal diseases in young children before use of 13-valent pneumococcal conjugate vaccine, Suzhou, China. Emerg Infect Dis. 2021;27(1):69.

  17. Wang JR, Liu FQ, Ao PR, Li X, Zheng H, Wu D. Detection of serotype distribution and drug resistance of Streptococcus pneumoniae isolated from pediatric patients. Laboratory Medicine. 2017;48(1):39-45.

  18. Ma MB, Yuan M, Li M, Li X, Huang H, Wang H. Serotype distribution and characteristics of the minimum inhibitory concentrations of Streptococcus pneumoniae isolated from pediatric patients in Kunming, China. Current Microbiology. 2021;78(3):954-60.

  19. Liang ZX, Fu JJ, Li L, Rongsong Y, Xu Sh, Chen J, et al. Molecular epidemiology of Streptococcus pneumoniae isolated from pediatric community-acquired pneumonia in pre-conjugate vaccine era in Western China. Ann Clin Microbiol Antimicrob. 2021;20(1):1-9.

  20. Bao YM, Wang Q, Yao KH, Xie G, Gao W, Huang L, et al. The changing phenotypes and genotypes of invasive pneumococcal isolates from children in Shenzhen during 2013-2017. Vaccine. 2019;37(49):7248-55.

  21. Chan KCC, Subramanian R, Chong P, Nelson A, Simon L, Martin L A, et al. Pneumococcal carriage in young children after introduction of PCV13 in Hong Kong. Vaccine. 2016;34(33):3867-74.

  22. Hon KL, Chan KH, Ko PL, Ho M, Yin K, Chan L. Change in pneumococcus serotypes but not mortality or morbidity in Pre-and Post-13-valent polysaccharide conjugate vaccine era: epidemiology in a pediatric intensive care unit over 10 years. Journal of Tropical Pediatrics. 2018;64(5):403-8.

  23. Li MC, Wang Y, Zhang H, Liu Y, Chen X, Yang H, et al. Serotype distribution and clinical characteristics associated with streptococcus pneumoniae among Chinese children and adults with invasive pneumococcal disease: a multicenter observational study. Human Vaccin Immunother. 2021;17(1):146-56.

  24. Moher D, Altman DG, Liberati A, Tetzlaff J, et al. PRISMA statement. Epidemiology. 2011; 22(1):128.

  25. Arksey H, O'Malley L. Scoping studies: towards a methodological framework. International Journal of Social Research Methodology. 2005;8(1):19-32.

  26. Chan D, Chan S, Wong C, Chan A. Immunisation coverage among children aged two to five: findings of the 2009 immunisation survey. Public Health & Epidemiology Bulletin. 2010;19:53-63.

  27. Hausdorff WP, Feikin DR, Klugman KP. Epidemiological differences among pneumococcal serotypes. The Lancet Infect Dis. 2005;5(2):83-93.

  28. Johnson HL, Deloria-Knoll M, Levine OS. Systematic evaluation of serotypes causing invasive pneumococcal disease among children under five: the pneumococcal global serotype project. PLoS medicine. 2010;7(10):e1000348.

  29. Chen KL, Zhang XY, Shan W, Zhao G, Zhang T. Serotype distribution of Streptococcus pneumoniae and potential impact of pneumococcal conjugate vaccines in China: a systematic review and meta-analysis. Hum Vaccin Immunother. 2018;14(6):1453-63.

  30. Arushothy R, Ahmad N, Amran F. Pneumococcal serotype distribution and antibiotic susceptibility in Malaysia: A four-year study (2014-2017) on invasive paediatric isolates. International Journal of Infectious Diseases. 2019;80:129-33.

  31. Singh J, Sundaresan S, Manoharan A. Serotype distribution and antimicrobial susceptibility pattern in children= 5 years with invasive pneumococcal disease in India-a systematic review. Vaccine. 2017;35(35):4501-9.

  32. Organización Mundial de la Salud. WHO publishes list of bacteria for which new antibiotics are urgently needed[Internet]. Ginebra: OMS; 2017[citado 05/03/2022]. Disponible en: Disponible en: https://www.who.int/news/item/27-02-2017-who-publishes-list-of-bacteria-for-which-new-antibiotics-are-urgently-needed 32.

  33. CHINET. Surveillance of bacterial resistance in children and newborns across China from 2014 to 2017. Zhonghua Yi Xue Za Zhi. 2018;8(40):3279-87.

  34. CHINET. Surveillance of bacterial resistance across tertiary hospitals in 2019. Chin J Infect Chemother. 2020;20(03):233?43.

  35. Sader H, Mendes RE, Le J, Denys J, Flamm R, Jones R. Antimicrobial susceptibility of Streptococcus pneumoniae from North America, Europe, Latin America, and the Asia-Pacific region: results from 20 years of the SENTRY antimicrobial surveillance program (1997-2016). Open Forum Infectious Diseases. 2019;6(sup.1):S14-S23.

  36. Dagan R, Juergens C, Trammel J, Patterson S, Greenberg D, Lavi N, et al. Efficacy of 13-valent pneumococcal conjugate vaccine (PCV13) versus that of 7-valent PCV (PCV7) against nasopharyngeal colonization of antibiotic-nonsusceptible Streptococcus pneumoniae. J Infect Dis. 2015;211(7):1144-53.

  37. Ladhani SN, Collins S, Djennad A, Shepard, Borrow R, Fry N, et al. Rapid increase in non-vaccine serotypes causing invasive pneumococcal disease in England and Wales, 2000-17: a prospective national observational cohort study. Lancet Infect Dis. 2018;18(4):441-51.

  38. Miyazaki H, Shibuya R, Midorikawa N, Shang B, Ohnishi M, Matsumoto T. Serotype distribution and antimicrobial susceptibility of Streptococcus pneumoniae strains isolated in Japan after introduction of the routine immunization program. J Infect Chemother. 2017;23(4):234-40.

  39. Zhao C, Li Z, Zhang F, Zhang X, Ji P, Zen J, et al. Serotype distribution and antibiotic resistance of Streptococcus pneumoniae isolates from 17 Chinese cities from 2011 to 2016. BMC Infect Dis. 2017;17(1):1-12.

  40. Jin P, Wu L, Oftadeh S, Kundinha T, Kong F, Zeng K, et al. Using a practical molecular capsular serotype prediction strategy to investigate Streptococcus pneumoniae serotype distribution and antimicrobial resistance in Chinese local hospitalized children. BMC Pediatric. 2016;16(1):1-10.

  41. Lyu S, Yao K-h, Dong F, Kundinha T, Kong F, Zeng K, et al. Vaccine serotypes of Streptococcus pneumoniae with high-level antibiotic resistance isolated more frequently seven years after the licensure of PCV7 in Beijing. Pediatr Infect Dis J. 2016;35(3):316-21.




2020     |     www.medigraphic.com